Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-018836
Filing Date
2021-08-06
Accepted
2021-08-06 07:30:57
Documents
52
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20210630_10q.htm   iXBRL 10-Q 846248
2 EXHIBIT 10.1 ex_272387.htm EX-10.1 6581
3 EXHIBIT 31.1 ex_266810.htm EX-31.1 12018
4 EXHIBIT 31.2 ex_266815.htm EX-31.2 12080
5 EXHIBIT 32.1 ex_266816.htm EX-32.1 6585
11 plxp20210630_10qimg001.gif GRAPHIC 3979
  Complete submission text file 0001437749-21-018836.txt   4479773

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA plxp-20210630.xsd EX-101.SCH 36741
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20210630_cal.xml EX-101.CAL 36756
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20210630_def.xml EX-101.DEF 315167
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20210630_lab.xml EX-101.LAB 292615
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20210630_pre.xml EX-101.PRE 332962
12 EXTRACTED XBRL INSTANCE DOCUMENT plxp20210630_10q_htm.xml XML 560001
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 211150560
SIC: 2834 Pharmaceutical Preparations